Allarity Therapeutics Inc. (NASDAQ: ALLR)
$0.20
+0.0040 ( +2.04% ) 3.0M
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Market Data
Open
$0.20
Previous close
$0.20
Volume
3.0M
Market cap
$5.09M
Day range
$0.18 - $0.20
52 week range
$0.18 - $69.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 81 | May 14, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
8-k | 8K-related | 15 | May 06, 2024 |
8-k | 8K-related | 15 | May 03, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
10-k/a | Quarterly Reports | 16 | Apr 29, 2024 |
8-k | 8K-related | 15 | Apr 18, 2024 |
8-k | 8K-related | 18 | Apr 05, 2024 |
8-k | 8K-related | 14 | Apr 04, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |